fbpx
Menu

COVID-19: let's try to understand it better

HomeForumsTough TimesCOVID-19: let's try to understand it better

New Reply
Viewing 15 posts - 31 through 45 (of 63 total)
  • Author
    Posts
  • #346774
    Anonymous
    Guest

    Dear Brittany:

    I read your post here and the thread you started and answered you on your own thread. I hope that you reply to me there, and that we communicate further on your thread.

    Dear Brandy:

    So good to read from you and to know you’ve been following my thread, and that we are on the same page! If you find that we are not on the same page on any particular topic or detail, let me know.

    Your grandparents were young people during the Spanish pandemic, how very interesting. I too wish you asked them about it, but back then, you had no idea that you will be finding yourself in a pandemic, so maybe it didn’t feel relevant to you at the time. But the concerned look on your grandmother’s face was telling!

    There is a book, I didn’t read it, about the Spanish flu, with the testimonies of people who lived through (don’t recall the title, but it’s easily goog-able. I may read parts of it if I can find it online.

    anita

    #347048
    Anonymous
    Guest

    Dear Reader:

    1. Wikipedia has the following, updated statistics in its “Coronavirus disease 2019” entry, as shown in the “fatality rate by age” graph: 0.2% is the fatality rate for ages 10-39; 0.4% for ages 40-49, 1.3% for ages 50-59, 3.6% for ages 60-69, 8% for ages 70-79, and 14.8% for age 80 and over.

    My Note: clearly, age is a huge factor determining fatality rate, from 0.2% up to 14.8%. Those 80 years and older have a mortality rate 74 times greater than the mortality rate of people 10-39 years old.

    The following is a simple calculation I made, (understanding that it will not result in the true mortality rate aka case fatality rate for Covid-19): I divided the available, updated number (worldometers)  of global deaths, 61,681 by 1,154,169 global tested & confirmed cases of infection (the actual number of infected people is much higher than the number of tested-and-confirmed cases), and got 5.344%. This number is very much an average, and it has little meaning as a predictor of mortality if age is not considered.

    2. A website: irishtimes, com/ news/ health/ tuberculosis- vaccine- potential- game- changer- in- covid- 19- fight has an article published today by Kevin O’Sullivan (an environmental and science editor) about a study that indicates that “the BCG vaccine for tuberculosis could help to protect against Covid-19″, and could help to “curb the pandemic, according to a leading immunologist“.

    The leading immunologist he mentions is Prof Luke O’Neil. Wikipedia states about the man, that he is a “professor of biochemistry in the School of Biochemistry and Immunology at Trinity College Dublin.. completed his postgraduate study at the University of London where he was awarded a PhD in Pharmacology.. Following his PhD, he was a postdoctoral researcher at Strangeways Research Laboratory in Cambridge… He has made pioneering discoveries in the area of metabolic programming in immunity.. He has co-founded Inflazome (Inlazome Ltd. engages in developing orally available drugs.. These drugs target the inflammatory driven diseases).. O’Neil was awarded the Royal Dublin Society & The Irish Times Robert Boyle Medal for scientific excellence in 2009, the Royal Irish Academy Gold Medal for Life Sciences in 2012 and the European Federation of immunology Societies Medal in 2014”- these are not all of his professional accomplishments.

    Before I quote from the article published today, I will quote from what wikipedia says on BCG vaccine: “Bacillus Calmette–Guérin vaccine is a vaccine primarily used against tuberculosis… BCG also has some effectiveness against Buruli ulcer infection and other nontuberculous mycobacteria infections. Additionally it is sometimes used as part of the treatment of bladder cancer”.

    And now, the article: “A study indicating that the BCG vaccine for tuberculosis could help to protect against Covid-19 is ‘a potential game-changer’ in global efforts to curb the pandemic’, according to a leading immunologist. The research indicating that countries whose populations have high levels of BCG vaccination had significantly fewer Covid-19 deaths was the most significant development since the virus has spread’, said Prof Luke O’Neill, who has specialised in study of the vaccine at Trinity College Dublin.

    While he stressed the research was largely a statistical one and so came with caveats, there was a case for authorities moving to provide a BCG vaccine top-up for everybody age over 70. ‘This is feasible and should be considered. It doesn’t mean we change behaviour, such as physical distancing and washing your hands,’ he said.'”.

    3. A website www. virology. ws, has an article in it from two days ago, April 2, 2020 by Dr. Gertrud U. Rey, (a trained virologist, a patent agent with expertise in the areas of pharmaceuticals and biotechnological arts, “has diverse working knowledge of molecular biology, virology, immunology, biochemistry and genetics”) called “Why is Covid-19 less severe in children?”

    It reads: “… most infected children experience mild symptoms, respond well to treatment, recover more quickly than adults, and have a better prognosis… According to the largest study of COVID-19 in children to date, more than 90% of children with laboratory- confirmed COVID-19 had asymptomatic, mild, or moderate disease. A comprehensive review of COVID-19 in children published on March 23 shows that even in Italy, the country with the highest number of COVID-19-related deaths so far, only 1.2% of patients were children, and none of these children died. What is the reason for this low morbidity and mortality in children? Although the answer isn’t clear, there are a few possible explanations… It is also possible that early childhood vaccines provide some protective immunity against SARS-CoV-2. For example, a study from 2008 shows that the measles vaccine elicits neutralizing (virus-inactivating) antibodies against SARS-CoV, the virus responsible for the 2003 coronavirus epidemic. Immunity derived from childhood vaccines typically wanes with age, thereby possibly increasing the risk of severe COVID-19 in the elderly.”

    I looked up the Abstract of the 2008 study she mentioned in www. ncbi. nlm. hih. gov/ pubmed/ 18346823. It is called: “Introduction of neutralizing antibodies and cellular immune responses against SARS coronavirus by recombinant measles viruses”. It reads: “Live attenuated recombinant measles viruses (rMV).. Both recombinant viruses stably expressed the corresponding SARS-CoV proteins.. The antibodies induced by rMV-S had a high neutralizing effect on SARS-CoV as well as on MV”.

    * to be continued.

    anita

    #347060
    Anonymous
    Guest

    Dear Reader:

    The current huge difference in the Covid-19 mortality rate by age  is not a reason whatsoever for younger people to feel confident. This trend of age difference in mortality rate can change if social distancing, quarantines and shut downs are not enforced because the more infections=> the more the virus mutates, and it can mutate to a form that will kill younger people, which is what happened a 100 years ago during the second wave of the Spanish flu pandemic, (Jan 1918- July 1918, was the first wave, the second wave started in August 2018), Wiki:

    The second wave of the pandemic was “much deadlier than the first. The first wave had resembled typical flu epidemics; those most at risk were the sick and elderly, while younger, healthier people recovered easily. By August, when the second wave began in France, Sierra Leone, and the United States, the virus had mutated to a much deadlier form. October 1918 was the deadliest month of the whole pandemic… the second wave was far more deadly; the most vulnerable people were those like the soldiers in the trenches – adults who were young and fit”.

    * A bit of an encouraging info regarding the Spanish flu: “After the lethal second wave struck in late 1918, new cases dropped abruptly – almost to nothing after the peak in the second wave. In Philadelphia, for example, 4,597 people died in the week ending 16 October, but by 11 November, influenza had almost disappeared from the city.… Another theory holds that the 1918 virus mutated extremely rapidly to a less lethal strain. This is a common occurrence with influenza viruses: there is a tendency for pathogenic viruses to become less lethal with time, as the hosts of more dangerous strains tend to die out”- this is about Influenza, not Covid-19, different virus, but it is good to know that a virus can mutate to a lesser lethal form.

    anita

    #348084
    Anonymous
    Guest

    Dear Reader:

    Back to existing vaccines and Covid-19. Wikipedia reads: “Bacillus Calmette-Guerin vaccine (BCG) is a vaccine primarily used against tuberculosis.. BCG also has some effectiveness against Buruli ulcer infection and other nontuberculous mycobacteria infections. Additionally it is sometimes used as part of the treatment of bladder cancer”-

    – so it is possible for a vaccine that was designed for a particular disease to be effective regarding diseases it was not designed for. It is possible for it to be used as treatment to diseases it was not designed to prevent or treat.

    From “neurosciencenews. com/ covid-19- bcg- vmp1002- vaccine- 15966”:

    “Previous studies in mice have shown the BCG vaccine is effective in protecting against several respiratory viral infections… mice suffering from influenza have fewer influenza A viruses in their blood if they had previously been vaccinated with BCG”

    “According to further studies, vaccination with BCG also increases the animals’ resistance to other viruses (e.g. herpes type 1 and 3). Apparently, a vaccination with BCG also activates the immune system against a viral infection. In this way, the vaccine reduces the risk of severe disease progression and thus lowers the death rate”.

    VPM1002, a vaccine candidate based on the tuberculosis BCG vaccine, may be effective in protecting against COVID-19… If effective against coronavirus, researchers hope the vaccine can bridge the time gap until a specific SARS-CoV-2 vaccine is available”.

    “A large-scale study is to be carried out at several hospitals in Germany and will include older people and health care workers. Both groups are particularly at risk of the disease… VPM1002 is safe and more effective than standard vaccination… The vaccine is currently being tested in a further Phase 3 study on adults volunteers in India. It should be completed by mid 2020”.

    “The higher safety profile of VPM1002 and the improved effectiveness give reason to hope that the new vaccine will also be better able to alleviate the symptoms of an infection with the SARS co-virus 2 than the BCC vaccine. ‘In addition, VPM1002 can be manufactured using state-of-the-art manufacturing methods which would make millions of doses available in a very short time… If the results are positive, VPM1002 could help ease the burden on healthcare systems until a vaccine specifically effective against SARS-CoV-2 becomes available.”

    — so, my understanding: the old vaccine against tuberculosis is BCG. An improved version of BCG is the new VPM1002, and the latter may be used to prevent and treat Covid-19 starting in mid 2020, and used until a specific vaccine for Covid-19 is developed,  sometime in 2021.

    anita

    #348124
    Anonymous
    Guest

    Dear Reader:

    It just so happened that I found out only a  moment ago, that I am not Covid-19 positive, just received that call- what a relief! I was prepared for a positive result and for a total lockdown in the house for two weeks, fearing of illness and death.

    Unfortunately, I am still at a risk of dying from other diseases (as we all are). Because I live in the U.S., I looked at the CDC’s (Center for Disease Control and Prevention) numbers for 2017: population close to 326 millions, total deaths, close to 3 million (863.8 deaths per 1000,000 population, which is, rounded: 8.64%).

    I will compare WHO’s estimation (March 3) of Covid-19 mortality rate of 3.4% (no consideration to age in death, or prior medical conditions prior to death), to the top causes of death in the US in 2017 (no consideration of age or prior medical conditions): Heart disease 0.2%, cancer 0.18%, unintentional injuries/ accidents 0.05%, chronic lower respiratory diseases 0.049%, Stroke 0.045%… Influenza and pneumonia 0.017%.-

    This means (considering 3.4% is an estimation, not a fact, and referring to facts regarding the US, 2017): the chance of dying from Covid-19 once infected is 17 times greater than dying from heart disease, 19 times greater than dying from cancer, 68 times greater than dying from accidental injuries (including traffic accidents).. and 200 times the chance of dying from influenza and pneumonia.

    Therefore, a seemingly low number of 3.4% mortality rate is in the grand scheme of things (US/ global population) translates to a huge number of deaths. Considering the high contagiousness of the virus, without social distancing and isolations, the number of deaths globally can easily be in the many millions, and.. considering that the more infections-> the more the virus mutates, and can mutate to a far more aggressive strain or strains, the number of global deaths can be even greater.

    I have more of an understanding today about the necessity of shutting down the global economy so to prevent a global death catastrophe-  way, way greater than the current(as I am about to submit this post) 79,152 deaths.

    anita

     

    #348284
    Anonymous
    Guest

    Dear Reader:

    * A disclaimer: I am not a doctor or a scientist, just a member (with a limited formal education in biology) studying the disease using online resources.

    A vaccine specific to Covid-19 is being worked on (the longest term process, not expected before 2021). A non-specific vaccine is being worked on (an improved version of the old BCG vaccine for tuberculosis,VPM1002, see yesterday posts, a shorter term process, expected as early as summer 2020).

    There is something else that’s being worked on, an ever shorter term process, expected to be available perhaps in a few weeks (?) It’s a non-vaccine method of passive immunization, and passive antibody therapy (also known as “convalescent plasma therapy), is the transferring of purified and concentrated antibodies produced by the  immune systems of those who have recovered from Covid-19 to people who are at risk of being infected (to prevent infection), and for people already infected with Covid-19 (to treat infection).

    Passive immunization happens naturally as antibodies from the body of a pregnant woman transfer to her baby, and it can happen artificially via blood transfusions.

    How antibodies work: the surface of viruses contain viral proteins that bind to host (human) cell receptors, making it possible for the virus to enter the human cell and infect it. Antibodies bind and block those surface viral proteins, and so, the virus is not able to enter and infect the human cell. This binding of the antibody to the virus is called neutralization, and it renders the virus no longer infectious.

    There are other two ways that the antibodies render the virus impotent: “antibody-dependent cellular cytotoxicity”, and “antibody- dependent cellular phagocytosis”,  in which the antibodies stimulate the person’s specialized immune cells to attack and disintegrate the virus, or to “eat” the virus, respectively.

    Passive antibody treatment is more effective when used for prevention of a disease than it is for treatment. To be used for treatment of a person already infected, it is most effective when administered shortly after the onset of symptoms, therefore, doctors will have to provide the treatment at the right time.

    The above information is taken from Wikipedia and www. medicalnewstoday. com/ articles/ can-an-old-method-help-doctors-fight-covid-19.

    According to a third source: markets. businessinsider. com/ news/ stocks/ Italian-biotech-leader-hopes-to-be-ready-with-plasma-based-treatment-for-covid-19-by-late-summer-of-2020 (April 7, 2020), a leading Italian biotech  (Kedrion, the world’s fifth biggest plasma company) announced two days ago that it started to develop a passive antibody therapy for treating the Covid-19 virus that can make it available to  patients in 3-6 months (July-Oct, 2020).

    The idea is “to collect plasma from convalescent patients in the next 30 days.. in close collaboration with hospitals from some of the most hard- hit regions of Italy… to use plasma from about 100 patients who have recovered from Covid-19 in order to develop a dosage that can be injected through either intravenous or intramuscular means.. to either patients who are suffering fromCovid-19 or to health care workers to provide temporary passive immunization… the Italian prototype is a plasma derivative which could be especially effective in treating patients in critical condition”.

    anita

    #348594
    Anonymous
    Guest

    Dear Reader:

    Currently, there are over 1.6 million global Coronavirus cases, and over 97,000 deaths globally. Most cases and deaths are in the U.S. (approaching half a million cases and 20,000 deaths, and most of these are in New York City).

    In  the worldometers Comparison section, it reads that “Every year an estimated 290,000 to 650,000 people die in the world due to complications from seasonal influenza”, so the comparison, very roughly,  is between less than 100,000 coronavirus deaths currently, in less than half a year, to almost 150,000 seasonal flu deaths, at the low end of the estimate,  in half a year.

    The reason the world economy is shut down is because this coronavirus, SARS-Cov-2, is  more contagious and more deadly than the seasonal influenza viruses, and because there is no vaccine or treatment for it, and because it is a new virus whose behavior is not well known and is still being studied, for example: it wasn’t known if it will mutate significantly within a short time and become way more contagious and deadly (it hasn’t), and because it spread too much before governments alerted the public and enforced adequate isolation practices.

    The current Covid-19 disease is a SARS disease (Severe Acute Respiratory Syndrome), a viral respiratory disease of zoonotic (animal) origin, caused by the virus SARS-Cov-2. The previous SARS was caused by the another coronavirus, SARS-Cov-1. It took place in Nov 2002-July 2003, originated in Beijing, China, and spread to 29 countries. There were 8,096 total global cases  (compared to current 1.6 millions), and 774 deaths (compared to current 97,000), a fatality rate of 9.6%, compared to WHO’s March 3 estimate of 3.4%  for this virus.

    MERS (Middle East Respiratory Syndrome), in 2002 (new infection cases still happening, not an epidemic),  was an epidemic of another viral respiratory disease of zoonotic origin, caused by another coronavirus called MERS-Cov. There were 2,494 cases and 858 deaths, fatality rate of 34.4%

    The transmission rate, or basic reproduction number of a virus (Ro), is a measure of how contagious the virus is. The Ro of MERS-Cov was 0.3-0.8. The Ro of SARS-Cov-1 was 2-5. The estimate of the Ro of the current SARS-Cov-2 is 1.4-3.8.

    Even though MERS’s fatality rate was much higher than the fatality rate of the current SARS, it was way less contagious. I figure, that’s one reason why MERS didn’t spread globally much, compared to the current SARS.

    anita

    #348852
    Anonymous
    Guest

    Dear Reader:

    In the following, “M” stands for 1 million people.

    1. The USA: it is a huge country with 50 states,: there are currently 521,816 cases in the USA, (1,576 cases per M)

    There are 180,458 cases in New York State (9,198 cases per M).

    There are 246 cases in Alaska (333 cases per M)

    * The Daily New Cases graph of the united state didn’t start to show a decline yet (the” flattening of the curve” didn’t occur yet).

    2. Australia is also a huge country: there are currently 6,303 cases in Australia (247 cases per M)

    * The flattening of the curve for Australia started at the end of March. The daily new cases graphs of the following states in Australia are congruent with this flattening: Queensland, Victoria, and Western Australia. On the other hand, in Tasmania, an island state in Australia, the flattening of the curve did not start yet.

    3. The Scandinavian countries:

    Sweden: 10,151 cases (1,005 cases per M).

    Norway: 6,403 cases (1,181 cases per M).

    Finland: 2,905 cases (524 cases per M)

    Denmark: 5,996 cases (1,035 cases per M).

    *** to be continued.

    anita

     

    #348988
    Anonymous
    Guest

    Dear Reader:

    Regarding #1 and 2 above: the infection cases in different areas within one country varies greatly, even in small countries. The areas most populated, with a bigger influx of people before lockdown measures, are the worst hit. So relaxing movement restrictions has to be custom made for each area within each country. The numbers in Worldometers, regarding the cases of infection in each country, as well as the graphs of daily new cases (reflecting the peaking and flattening of the curve), are averages. In reality, a flattening graph for a country, does not indicate a flattening graph in each and every area in that country.

    Regarding #3 above, coronavirus in the Scandinavian countries, according to Wikipedia which has an entry for coronavirus in each country:

    Denmark’s first confirmed case of Covid-19 was on Feb 27: it was a man who had  been skiing in Lombardy, Italy and returned to Denmark Feb 24. Denmark was among the first European countries to introduce lockdown measures, starting March 13.

    Norway’s first confirmed case of Covid-19 was on Feb 26: a woman who returned from China the previous week. A national lockdown was announced on March 12: schools, kindergartens, fitness centers, hair salons etc. were closed, sport and cultural events and gatherings were banned, and restrictions applied to restaurants, in line with those introduced in other European countries like Denmark and Italy.

    Finland’s first confirmed case of Covid-19 was on January 29: a Chinese tourist from Wuhan touring Finland tested positive for the virus. The Finnish government declared a state of emergency on March 16: all schools were closed, not including early education, theatres, libraries, museums, etc. shut down, public gatherings were limited to 10 people, and people  over the age of 70 were to avoid human contact, if possible, outsiders were forbidden from entering healthcare facilities and hospitals, including relatives of critically ill people.

    Sweden’s first confirmed case of Covid-19 was on January 31: a woman returning from Wuhan tested positive. On February 26, following outbreaks in Italy and in Iran, multiple travel-related clusters appeared in Sweden.

    But “Sweden has, unlike many other countries, not applied any lockdown, with most measures being voluntary.. The Public Health Agency and government of Sweden issues recommendations to work from home, if possible;  for people above 70 to stay at home; and issued general recommendations to avoid unnecessary travel within the country and to promote social distancing between people. Those with even minimal symptoms which could be Covid-19 are recommended to stay home”.

    An April 9 article (time. com/ 5817412/ Sweden- coronavirus) reads: “As many public spaces throughout Europe empty out- with citizens only leaving for essential groceries or medication- life in Sweden is carrying on, mostly as usual. Children walk to school while adults meet up for dinner at their local bar.. Only the vulnerable have been advised to  isolate and some are working from home… The Swedish Public Health Agency.. does not call for lockdown measures”.

    “Anders Tegnell, Sweden’s chief epidemiologist overseeing the government’s response to Covid-19 has said the government should allow the virus to spread slowly through the population, an approach initially employed by the United Kingdom and the Netherlands before both countries rapidly changed strategy… Tegnell told Swedish TV on April 5 that Covid-19 could be stopped by ‘herd immunity or a combination of immunity and vaccination.’ (A vaccine for Covid-19 is likely at least 14 months away). But many experts throughout Sweden say the current strategy is dangerous… the current approach will ‘probably end in a historical masacare’.

    A doctor working in a hospital, who asked to remain anonymous, said that “healthcare workers at his hospital who have tested positive for the virus but are asymptomatic have been advised to continue working… Opinion polls show that citizens trust the Public Health Authority, with 48% saying they have very high or high confidence in the institution.. Swedes have above-average confidence in their politicians, who in turn, trust citizens to follow their advice.”

    “Even though 40% of Swedish households are single-person households without children, some experts say that Covid-19 can still spread rapidly and widely in these conditions. Sweden has the second lowest number of critical care beds in Europe after Portugal, with only 5 beds for every 100,000 inhabitants, and the healthcare would likely be unable to handle a severe Covid-19 outbreak.”

    Healthline. com/ health/ herd- immunity # takeaway, reads regarding herd immunity: “Herd immunity happens when so many people in a community become immune to an infectious disease that it stops the disease from spreading. It can happen in two  ways: 1. Many people contract the disease and in time build up an immune response to it (natural immunity). 2. Many people are vaccinated against the disease”.

    “For some diseases, herd immunity can go into effect when 40 percent of the people in a population become immune to the disease, such as through vaccination. But in most cases, 80 to 95 percent of the population must be immune to the disease to stop its spread. For example, 19 out of every 20 people must have the measles vaccination for herd immunity to go into effect and stop the disease.”

    “Natural immunity can help create herd immunity, but it doesn’t work as well as vaccinations. There are several reasons for this: Everyone would have to contract the illness once to become immune; Contracting an illness can have health risks, sometimes serious; You may not know if you’ve contracted an illness or if you’re immune to  it.”

    “For most healthy people, herd immunity isn’t a good alternative to getting vaccinated.. You can help  build herd immunity to certain diseases in your community by making sure you and your family have up-to-date vaccinations.”

    But of course, there is no vaccine for Covid-19.

    “There are several reasons why herd immunity isn’t the answer to stopping the spread of the new coronavirus:

    1. There isn’t yet a vaccine for SARS-Cov-2.

    2. The research for antiviral and other medications to treat Covid-19 is ongoing.

    3. Scientists don’t know if you can contract SARS-Cov-2 and develop Covid-19 more than  once.

    4. People who contract SARS-Cov-2 and develop Covid-19 can experience serious side effects. Severe cases can lead to death…

    8. Hospitals and healthcare systems may be overburdened if many people develop Covid-19 at the same time.”

    Back to Worldometers:

    Sweden had 10,151 cases yesterday, and 10,483 cases today (an increase of  332)

    Norway had 6,403 cases yesterday, and 6,485 cases today (an increase of  82).

    Finland had 2,905 cases yesterday, and 2,974 cases today (an increase of  69).

    Denmark had 5,996 cases yesterday, and 6,174 cases today (an increase of 178).

    anita

    #349004
    sonu
    Participant

    its very dangerous but always care your self and social distance maintain god keep save world

     

    #349178
    Anonymous
    Guest

    * Thank you for the note, sonu.

    Dear Reader:

    There will be lots of numbers in the following, many of these numbers are taken from worldometers, and from worldpopulationreview. com. For anyone who tends to get dizzy when exposed to many numbers, this is a warning!

    The population density in the USA is 35 people per square kilometer. New York City (NYC) is the most densely populated city in the United States. According to 2018 numbers (Wikipedia), with over 8 million people, its population density is about 10,713 people per square kilometer. NYC is the reason why 34% of all US Covid-19 cases and 42% of all US Covid-19 deaths are in the state of New York.

    The population density in Italy is 206 people per square km, 2,029 in Milan in the north, 2,263 in the most populated Rome. The population density in Spain is 91, and 779 in Madrid, the most populated city in Spain.

    Let’s look at the Scandinavian countries: of the four, Denmark is the most densely populated: 134 people per square kilometer, 6 times more than Sweden (22 people per square km), almost 8 times more than Norway (17 people per square km), and more than 8 times than that of Finland (16 people per square km).

    Oslo (Norway), has the population density of 1,400 people per square km, and part of Oslo (the Urban municipality) has the population density of 3,300 people per square km. Stockholm is the most populated city in Sweden with a population density of 4,800 people per square km. The most populated city in Finland is Helsinki with a population density of 3,050 people per square km, with a 16,494 people per square km in the inner city.

    Most of the Covid-19 cases are in Sweden, almost 11,000 cases, next is Norway, just over 6,500, next  is Denmark, just over 6,300, and last is Finland with just over 3,000.

    In Sweden the current number of deaths is 919:  91 deaths per one million (M) population.  Denmark: 285 deaths, 49 deaths per M, Norway: 133 deaths, 25 deaths per M, Finland: 59 deaths, 11 deaths per M,

    Globally, 95% of the active cases are in mild condition and 5% of the cases are in a serious or critical condition. This 95%- 5% ratio has been consistent for the longest time. In Sweden, 91% are in mild condition, and 9% are in a serious or critical condition.

    Leaving the Scandinavian countries for a moment, the USA, leading the world in numbers of cases and deaths, there are currently 22,115 deaths, 67 deaths per M. Spain: 17,489 deaths, 374 deaths per M. Italy: 19,899 deaths, 329 deaths per M.

    My comment: there is a disproportionate number of Covid-19 deaths in Sweden: roughly 8 times that of Finland, 4 times that of Norway, and twice that of Denmark (even though Denmark is 6 times more populated than Sweden).

    Going outside Scandinavia, Sweden has more deaths per M than the USA (91 compared to 67), but less than that of Spain and Italy (91 compared to 374 and 329 respectively).

    Sweden is very different from Italy and Spain: 40% of Swedish households are single-person households without children, and 23% of households are of cohabitating or married couples living without children. On the other hand, Spain and Italy are known for their high rate of multi-generational families, all living together. In Spain, over half of people  between the ages of 25 and 29 are still living with their parents. In Italy, about 67% of 18-34 year old Italians live with their parents.

    -it is a sort of a high population density within the home, which includes the aging, which are way more vulnerable to Covid-19 than the young.

    Taken all the above into account, what is working for Sweden’s advantage is the overall low population density and rarity of multi-generational households (a sort of low population density outside and inside homes): the Daily New Cases in Sweden, worldometers, shows a decline in new cases since April 9, four days ago.

    Sweden’s lax attitude toward the pandemic (having issued minimal restrictions on people’s movements, no lockdowns, and their herd immunity attitude), seems to correspond with more severe symptoms in  those infected and in more deaths.

    It remains to be seen if Sweden’s new daily cases continues to decline (the flattening of the curve), and whether the significantly high number of deaths continue to rise.

    anita

     

     

    #349184
    Anonymous
    Guest

    Clearing the above, copied:

    Dear Reader:

    There will be lots of numbers in the following, many of these numbers are taken from worldometers, and from worldpopulationreview. com. For anyone who tends to get dizzy when exposed to many numbers, this is a warning!

    The population density in the USA is 35 people per square kilometer. New York City (NYC) is the most densely populated city in the United States. According to 2018 numbers (Wikipedia), with over 8 million people, its population density is about 10,713 people per square kilometer. NYC is the reason why 34% of all US Covid-19 cases and 42% of all US Covid-19 deaths are in the state of New York.

    The population density in Italy is 206 people per square km, 2,029 in Milan in the north, 2,263 in the most populated Rome. The population density in Spain is 91, and 779 in Madrid, the most populated city in Spain.

    Let’s look at the Scandinavian countries: of the four, Denmark is the most densely populated: 134 people per square kilometer, 6 times more than Sweden (22 people per square km), almost 8 times more than Norway (17 people per square km), and more than 8 times than that of Finland (16 people per square km).

    Oslo (Norway), has the population density of 1,400 people per square km, and part of Oslo (the Urban municipality) has the population density of 3,300 people per square km. Stockholm is the most populated city in Sweden with a population density of 4,800 people per square km. The most populated city in Finland is Helsinki with a population density of 3,050 people per square km, with a 16,494 people per square km in the inner city.

    Most of the Covid-19 cases are in Sweden, almost 11,000 cases, next is Norway, just over 6,500, next  is Denmark, just over 6,300, and last is Finland with just over 3,000.

    In Sweden the current number of deaths is 919:  91 deaths per one million (M) population.  Denmark: 285 deaths, 49 deaths per M, Norway: 133 deaths, 25 deaths per M, Finland: 59 deaths, 11 deaths per M.

    Globally, 95% of the active cases are in mild condition and 5% of the cases are in a serious or critical condition. This 95%- 5% ratio has been consistent for the longest time. In Sweden, 91% are in mild condition, and 9% are in a serious or critical condition.

    Leaving the Scandinavian countries for a moment, the USA, leading the world in numbers of cases and deaths, there are currently 22,115 deaths, 67 deaths per M. Spain: 17,489 deaths, 374 deaths per M. Italy: 19,899 deaths, 329 deaths per M.

    My comment: there is a disproportionate number of Covid-19 deaths in Sweden: roughly 8 times that of Finland, 4 times that of Norway, and twice that of Denmark (even though Denmark is 6 times more populated than Sweden).

    Going outside Scandinavia, Sweden has more deaths per M than the USA (91 compared to 67), but less than that of Spain and Italy (91 compared to 374 and 329 respectively).

    Sweden is very different from Italy and Spain: 40% of Swedish households are single-person households without children, and 23% of households are of cohabitating or married couples living without children. On the other hand, Spain and Italy are known for their high rate of multi-generational families, all living together. In Spain, over half of people  between the ages of 25 and 29 are still living with their parents. In Italy, about 67% of 18-34 year old Italians live with their parents.

    -it is a sort of a high population density within the home, which includes the aging, which are way more vulnerable to Covid-19 than the young.

    Taken all the above into account, what is working for Sweden’s advantage is the overall low population density and rarity of multi-generational households (a sort of low population density outside and inside homes): the Daily New Cases in Sweden, worldometers, shows a decline in new cases since April 9, four days ago.

    Sweden’s lax attitude toward the pandemic (having issued minimal restrictions on people’s movements, no lockdowns, and their herd immunity attitude), seems to correspond with more severe symptoms in  those infected and in more deaths.

    It remains to be seen if Sweden’s new daily cases continues to decline (the flattening of the curve), and whether the significantly high number of deaths continue to rise.

    anita

    #349520
    Anonymous
    Guest

    Dear Reader:

    A follow up on Scandinavia, today’s numbers (worldometers):

    Sweden: 11,445 cases, total deaths: 1,033 (9% of the number of cases), an increase of 114  deaths from yesterday (an 11% increase).Currently 102 deaths per million. 9% of patients are in serious or critical condition, 91% are in mild condition.

    Denmark: 6,511 cases, total deaths: 299 (4.6% of the number of cases), an increase of 14 deaths from yesterday, (a 4.7 % increase). Currently 52 deaths per million. 3% of patients are in serious or critical condition, 97% are in mild condition.

    Norway: 6,623 cases, total deaths: 139 (2% of the number of cases), an increase of 6 deaths from yesterday (a 4.3% increase). Currently 26 deaths per million. 4% of patients are in serious or critical condition, 96% are in mild condition.

    Finland: 3,161 cases, total deaths: 64 (2% of the number of cases), an increase of 5 deaths from yesterday (a 7.8% increase). Currently 12 deaths per million . 3% of patients are in serious or critical condition, 97% are in mild condition.

    anita

     

     

    #349892
    Anonymous
    Guest

    Dear Reader:

    In my April 12 post, I quoted from Healthline regarding herd immunity: “Herd immunity happens when so many people in a community become immune to an infectious disease that it stops the disease from spreading. It can happen in two ways: 1. Many people contract the disease and in time build up an immune response to it (natural immunity) 2. Many people are vaccinated against the disease”- because vaccination is not possible this year, let’s look at natural immunity, that is, people who were infected, producing antibodies that protect them from getting infected a second time:

    www. msn. com/ en-ca/ health/ medical/ can-you-catch-coronavirus-twice-south-korea-reports-91-recovered-patients-tested-positive,  April 11, reads: “The Korea Centers for Disease Control and Prevention announced that 91 people who had previously cleared of the virus had tested positive… KCDC director Jeong Eun-kyeong said Friday that health investigators were still working to determine whether the patients had been ‘reactivated’ rather than being re-infected. ‘While we are putting more weight on reactivation as the possible cause, we are conducting a comprehensive study on this.’ Jeong said… The question about reinfection also arose last month after health officials in Japan said a woman who had been declared virus-free had tested positive again…Although uncommon, some viruses stay dormant inside host cells until they’re reactivated. Chickenpox, for example, can occur in children but can later reactivate in adults as shingles.”

    “David Kelvin, a professor of microbiology and immunology at Dalhousie University, said reinfection is ‘unlikely’ and there could be several possible explanations for the new cases, including that the individual never completely cleared the original infection or the use of faulty test kits… If it’s true that people are re-infected, we’re in for a really difficult time. I find it hard to believe, but it’s possible”.

    “Kelvin said there have been few studies done on reinfection, but they have so far found it’s unlikely that people can get the novel coronavirus more than once. He pointed to one small study from China that found antibodies in rhesus monkeys kept primates that had recovered from Covid-19 from becoming infected again upon exposure to the virus”.

    “Whether or not people who have Covid-19 can be re-infected is currently being studied closely by health experts… Anthony Fauci, the director of the U.S. National Institute of Allergy and Infectious Diseases, told the Journal of the American Medical Association this week that reinfection was unlikely. ‘If a person gets infected with coronavirus A, and then gets reinfected with a coronavirus, it may be coronavirus B’, Fauci said. ‘But right now, we don’t think that this is mutating to the point of being very different.”

    www. iflscience. com/ health-and-medicine, on April 14,  on the same topic, reads that Jeong Eun-kyeong, director of the Korean Center of Disease Control and Prevention (KCDC), told reporters on April 13: “Investigators are looking into whether the cause of the relapse is the virus being reactivated or reinfection with the virus”. The article continues: “The big questions are whether or not people are at risk of falling ill again and whether they transmit the infection to others. In short, no one knows yet. As with many aspects of this novel disease, the scientific community has little in the way of pre-existing knowledge on Covid-19 and the planet’s understanding is constantly evolving”.

    “The US Centers for Disease Control and Prevention (CDC) .. ‘Patients with MERS-Cov (a related coronavirus) are unlikely to be re-infected shortly after they recover, but it is not yet known whether similar immune protection will be observed for patients with Covid-19′”.

    Professor Jimmy Whitworth, an expert in international public health from London School of Hygiene and Tropical medicine  said: “I suspect it’s a technical issue, rather than a repeat infection.. It looks like you are immune for getting it again, but for how long, we don’t know yet”.

    My summary:

    1. SARS-Cov-2, the virus causing Covid-19,  is a new virus which appeared in humans for the very first time in Nov 2019, and got the massive attention of the international scientific community sometime this year, not before. Scientists don’t yet know this virus well.

    2. It is possible that the positive results in patients that recovered from Covid-19 are false positives, or that their previous negative results were false negatives, and/ or other technical malfunction, and therefore, these reported positives do not mean that recovered patients were re-infected.

    3. It is possible that this new virus, after infecting a patient, goes dormant, similar to a herpes virus that goes dormant following the initial, first activations, then gets re-activated every so often, staying in the person’s body lifetime.

    4. It is possible that this new virus will significantly mutate to a new form or forms, so that a person’s antibodies following the first infection are not effective when a second infection takes place. In this case, a person’s natural immunity for the original virus will be limited in time. But so far, this virus didn’t mutate significantly (all viruses mutate to some extent when infecting new individuals). If this new virus does mutate significanlty, it can re-infect recovered Covid-19 patients in the same way that mutated/new flu viruses re-infect recovered flu patients.

    anita

     

     

     

     

    #350086
    Anonymous
    Guest

    Dear Reader:

    In this post (and future posts) I will refer to the coronavirus responsible for the 2002-2003 SARS epidemic as Cov-1 (short for SARS-Covid-1), and to the coronavirus responsible for the current SARS pandemic as Cov-2, short for SARS-Cov-2. I will refer to the SARS epidemic of 2002-03 as SARS,(Severe Acute Respiratory Syndrome), and to the current SARS pandemic as Covid-19 (Coronavirus Disease 2010).

    www. businessinsider. com/ china-Wuhan-coronavirus-compared-to-sars-2020-1(paraphrased by me, plus quotes): The two viruses: Cov-1, responsible for the SARS epidemic of 2002-2003 (WHO declared the epidemic contained on July 5, 2003), and Cov-2, responsible for the current SARS pandemic (Covid-19) of 2019-?, share 80% of their genetic codes. The two viruses are zoonotic, meaning, they jumped from animals to humans. The original hosts of both were bats. Both were passed through the saliva and poop of bats to intermediate animals before jumping into humans.

    Both Cov-1 and Cov-2 enter the host cell of animals/ humans by bonding to receptors in the animal/human lung cells, receptors that are called ACE2. But Cov-2 forms a bond with ACE2 that is ten times stronger than the bond Cov-1 formed with same receptor. This 10 times stronger bond between Cov-2 and the human lung receptor ACE2, can explain why Covid-19 is “so much more contagious than SARS and more easily jumps from person to person”.

    Cov-2 “is nearly identical to other coronaviruses circulating in Chinese bat populations- 96% of the genetic codes match”.

    www. medicalnewstoday. com/ articles/ how-do-sars-and-mers-compare-with-covid-19:

    A summary comparison of SARS vs Covid-19:

    * total number of cases-  SARS: 8,439 (87% of all cases were in China and Hong Kong, 29 countries and territories total); Covid-19 (current): 2,228,784. (264 times the number of SARS total cases, in 210 countries and territories).

    * Number of cases in the U.S-  SARS: 73; Covid-19 (current): 686,431. (9,403 times the number of U.S SARS cases).

    * Total number of deaths- SARS: 812; Covid-19 (current): 150,708. (185 times the number of SARS deaths).

    * Case Fatality Rate (CFR)-  SARS: 9.6% (11% according to Wikipedia); Covid-19 current estimates: varies, most about 1.38%- 3.4%, SARS therefore has “significantly higher case fatality rates than Covid-19. Yet Covid-19 is more infectious” (Wikipedia: SARS Ro= 2-4, Covid-19: “Initial studies suggested ..a basic reproduction number of 2.2-2.7, but a study to be published on April 07, 2020 calculated a much higher median Ro value of 5.7%”). Ro is a basic reproduction number indicating how many people are infected by one infected person.

    * The following are the same or similar for both: mode of transmission (droplets produced by breathing, talking, sneezing, coughing), mean incubation period (5 days), key symptoms are similar, and in both people with underlying medical conditions were/ are a risk group.

    www. webmd. com/ lung/ news/ ..sars-timeline-of-outbreak(quotes):

    Nov 16, 2002: the first case of an atypical pneumonia is reported in the Guangdon province of Southern China.

    Feb 26, 2003: first cases of unusual pneumonia reported in Hanoi, Vietnam.

    ..March 11, 2003: a similar outbreak of a mysterious respiratory disease is reported among healthcare workers in Hong Kong.

    March 12, 2003: WHO (World Health Organization) issues a global alert about a new infectious disease of unknown origin in both Vietnam and Hong Kong.

    ..March 15, 2003: CDC (US Center for Disease Control and Prevention) issues a travel advisory stating that persons considering travel to the affected areas in Asia (Hong Kong, Singapore, Vietnam and China).

    March 17, 2003: an international network of 11 leading laboratories is established to determine the cause of SARS and develop potential treatments. And CDC holds its first briefing on SARS and says the first 14 suspected SARS cases are being investigated in the U.S.

    ..April 28, 2003: WHO removes Vietnam from list of SARS affected areas, making it the first country to contain SARS successfully. WHO also lifts travel advisory to Hanoi, Vietnam.

    May 6, 2003: the CDC lifts its travel advisory for Singapore because no new cases of SAR had been reported in 20 days.

    ..May 17, 2003: WHO extends its travel warning to include Hebei Province, China.

    ..May 20, 2003: the CDC lifts its travel alert for Toronto, Canada, because more than 30 days have elapsed since the last case of SARS was reported there.

    May 23, 2003: the WHO lifts its advisory against all but essential travel to Hong Kong and the Guangdong province of China saying the SARS situation in those areas has  improved significantly.

    ..June 24, 2003: WHO removes its last remaining SARS travel warning for Beijing, China.

    My thoughts based on the above:

    1. Coronaviruses, like all viruses, mutate. Cov-2 has 80% of the genome of Cov-1 which has been contained 17 years ago. Cov-2 has 96% of the genome of coronaviruses recently found in bats. This means that (very roughly and in a very simplified way), the virus mutated 16% in 17 years.

    2. Both SARS and Covid-19, started in China: SARS started in China’s Guangdong Province, November 2002, and Covid-19 started in China’s Hubei Province (Wuhan), December 2019. SARS spread mostly in China and Hong Kong, and to total 29 countries and territories. Covid-19 spread to 210 countries and territories, and produced 9,403 more cases of infections so far, 185 times more deaths so  far.

    Even though a higher percentage of Covid-1 infections ended in death (its mortality rate/ Case Fatality Rate/CFR is higher), Covid-2 produced 185 times more deaths than Covid-1, so far, because it is more contagious:

    A lower percentage/CFR of a higher number of infections (because of a higher Ro) gives a bigger number of deaths than does a higher percentage/CFR of a lower number of infections (because of a lower Ro). In other words, a higher infection rate when not contained, and a lower mortality rate results in more deaths than a lower infection rate and a higher mortality.

    3. The events of Nov 2002 through June 2003, a few of which I included above, are similar to what I expect to happen next during this pandemic, in that WHO, the CDC and other official organizations in different countries, will announce, as time goes by, new travel alerts, travel advisories, social restrictions, removals of alerts, removal of advisories, removal of restrictions, re-establishing alerts and restrictions and so on and on, in different areas within a country, in different countries, according to changing data, until a vaccine becomes readily available to the world population.

    * On May 20, 2003, the CDC lifted its travel alert to Toronto, Canada  because “more than 30 days have elapsed since the last case of SARS was reported there”. There were about 400 cases of SARS infection in Canada, but more than 31,000 Covid-19 cases of infection in Canada currently. I imagine the CDC will not wait 30 days of having no new Covid-19 cases in any area before lifting a travel alert. I imagine alerts and restrictions will be lifted when the number of new infections per day, in an area, over time (the flattening of the curve) lessens, rather than the unimaginable, pre-vaccine situation of having zero new cases anywhere.

    * In March 17, 2oo3, for the first time “an international network of 11 leading laboratories” was established to determine the cause of SARS (Cov-1) and develop potential treatments. Seventeen years later, a whole lot more laboratories, and international networks are working on studying Cov-2, developing treatments (shorter term) and vaccines (longer term). A lot more attention and resources are put in the effort now than 17 years ago.

    More later.

    anita

    • This reply was modified 4 years, 8 months ago by .
Viewing 15 posts - 31 through 45 (of 63 total)

You must be logged in to reply to this topic. Please log in OR register.